IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Fusion Pharm Inc (FSPM)

CUSIP: 36113H100 | NYSE | Healthcare · Pharmaceutical Retailers | 6 institutional holders

Quarters

Q3 2026Q1 2026Q3 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Ascentis Independent Advisors2,000
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Ascentis Independent Advisors
2,000$00.0%GrowthLowDallas, TX2026-11-03